Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

IMNPQ

(IMNPQ)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:IMNPQ

1 2 3 4 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
04/02/2020	17h46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:IMNPQ
12/08/2019	16h04	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:IMNPQ
08/03/2019	22h39	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:IMNPQ
07/02/2019	22h21	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	USOTC:IMNPQ
17/01/2019	19h59	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:IMNPQ
08/01/2019	16h16	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	USOTC:IMNPQ
06/12/2018	15h53	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:IMNPQ
21/11/2018	22h11	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:IMNPQ
20/11/2018	15h58	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:IMNPQ
14/11/2018	22h26	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:IMNPQ
08/11/2018	22h18	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:IMNPQ
29/10/2018	22h24	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:IMNPQ
17/07/2018	14h30	GlobeNewswire Inc.	Immune Pharmaceuticals Announces Filing of Proxy Statement for Reverse Stock Split	USOTC:IMNPQ
09/07/2018	13h00	GlobeNewswire Inc.	WuXi Biologics and Immune Pharmaceuticals Announce Late-phase Development and Manufacturing Partnership for a First-In-Class ...	USOTC:IMNPQ
08/06/2018	14h30	GlobeNewswire Inc.	Immune Pharmaceuticals Announces Receipt of Nasdaq Listing Determination	USOTC:IMNPQ
23/05/2018	14h00	GlobeNewswire Inc.	Immune Pharmaceuticals Provides a Pipeline Update	USOTC:IMNPQ
15/05/2018	15h00	GlobeNewswire Inc.	Immune Pharmaceuticals Presents Updated Positive Results from Phase 2 Trial of Bertilimumab in Bullous Pemphigoid	USOTC:IMNPQ
07/05/2018	14h30	GlobeNewswire Inc.	Immune Pharmaceuticals Provides Update on Plans for Oncology Subsidiary, Cytovia, Inc.	USOTC:IMNPQ
02/04/2018	23h16	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:IMNPQ
14/02/2018	21h09	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:IMNPQ
14/12/2017	20h54	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:IMNPQ
19/10/2017	21h20	Edgar (US Regulatory)	Registration of Additional Securities (up to 20%) (s-1mef)	USOTC:IMNPQ
19/10/2017	12h01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:IMNPQ
14/08/2017	22h53	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:IMNPQ
31/03/2017	22h04	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:IMNPQ
23/03/2017	11h05	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	USOTC:IMNPQ
31/01/2017	22h03	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	USOTC:IMNPQ
02/12/2016	12h04	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	USOTC:IMNPQ
20/08/2016	00h00	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	USOTC:IMNPQ
10/08/2016	13h15	InvestorsHub NewsWire	Friendable, Inc. (OTC Pink: FDBL) – Re-Signs TKA – More Celebrity Endorsements, Adds Consumer Brand Partnerships	USOTC:IMNPQ

Showing the most relevant articles for your search:USOTC:IMNPQ

1 2 3 4 Suivant >>

Mining Minerals & Metals

AllianceBernstein

Eco Atlantic Oil and Gas

Foresight Solar & Techno...

Oceanpact Servicos Marit... ON

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales